{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T20:00:40Z","timestamp":1774555240985,"version":"3.50.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-007885"],"award-info":[{"award-number":["MJFF-007885"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["F99NS108458"],"award-info":[{"award-number":["F99NS108458"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Genetic and neuropathological evidence strongly implicates aberrant forms of \u03b1-synuclein in neurodegeneration. Antibodies specific for \u03b1-synuclein phosphorylated at serine 129 (pS129) are selective for the pathological protein aggregates that are characteristic of Parkinson\u2019s disease (PD) and other synucleinopathies, such as dementia with Lewy bodies (DLB) and multiple system atrophy (MSA). Although the etiology of most synucleinopathies remains uncertain, a large body of evidence points to mitochondrial dysfunction. The recent development of animal models based on intracranial injection of \u03b1-synuclein pre-formed fibrils (PFFs) has provided a valuable experimental system in which to study the spread and neurotoxicity of \u03b1-synuclein aggregates, yet the effects of PFF-induced protein aggregates on mitochondrial function and dynamics have not been rigorously examined in vivo. To help fill this knowledge gap, we injected the striatum of mice unilaterally with well-characterized small length (&lt;\u200930\u00a0nm) PFFs or monomeric \u03b1-synuclein control and measured the distribution and extent of pS129 \u03b1-synuclein-immunoreactive aggregates, the loss of tyrosine hydroxylase-immunoreactive neurons in the substantia nigra, the abundance of mitochondrial proteins, and the activity of mitochondrial respiratory chain components at 3\u00a0months and 6 months post injection. Intrastriatal injection of small length PFFs, but not monomeric \u03b1-synuclein control, induced robust pS129 \u03b1-synuclein immunoreactive inclusions in the cortex, ventral midbrain, and striatum, as well as in rarely reported brain regions, such as the hippocampus, as early as 3\u00a0months post injection. Significant loss of nigral tyrosine hydroxylase-immunoreactive neurons was observed in the PFF-injected hemisphere at 3\u00a0months and 6\u00a0months post injection. The unilateral striatal injection of small length PFFs also caused hemisphere-dependent and treatment-dependent changes in the cortical levels of mitochondrial proteins such as VDAC1, COX-IV, and DRP-1, as well as functional changes in mitochondrial complex I activity in the contralateral striatum. Together, these data demonstrate that intrastriatal injection of mice with small length PFFs induces extensive bilateral protein aggregates, significant unilateral nigral cell loss, and altered contralateral levels of mitochondrial proteins and respiratory chain activity. Our data suggest this animal model may be useful for studying the role of mitochondrial dysfunction in \u03b1-synucleinopathies, for studying the hemisphere-dependent effects of \u03b1-synuclein aggregates, and for testing neuroprotective therapies that target mitochondrial dysfunction and protein aggregation.<\/jats:p>","DOI":"10.1186\/s40478-022-01374-z","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T10:04:20Z","timestamp":1653300260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Analysis of hemisphere-dependent effects of unilateral intrastriatal injection of \u03b1-synuclein pre-formed fibrils on mitochondrial protein levels, dynamics, and function"],"prefix":"10.1186","volume":"10","author":[{"given":"Rose B.","family":"Creed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeel A.","family":"Memon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sindhu P.","family":"Komaragiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep K.","family":"Barodia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5172-9841","authenticated-orcid":false,"given":"Matthew S.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,23]]},"reference":[{"key":"1374_CR1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.nbd.2017.05.014","volume":"105","author":"H Abdelmotilib","year":"2017","unstructured":"Abdelmotilib H, Maltbie T, Delic V, Liu Z, Hu X, Fraser KB, Moehle MS, Stoyka L, Anabtawi N, Krendelchtchikova V et al (2017) alpha-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration. Neurobiol Dis 105:84\u201398. https:\/\/doi.org\/10.1016\/j.nbd.2017.05.014","journal-title":"Neurobiol Dis"},{"key":"1374_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1212\/01.wnl.0000271080.53272.c7","volume":"70","author":"TB Ahn","year":"2008","unstructured":"Ahn TB, Kim SY, Kim JY, Park SS, Lee DS, Min HJ, Kim YK, Kim SE, Kim JM, Kim HJ et al (2008) alpha-Synuclein gene duplication is present in sporadic Parkinson disease. Neurology 70:43\u201349. https:\/\/doi.org\/10.1212\/01.wnl.0000271080.53272.c7","journal-title":"Neurology"},{"key":"1374_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.608026","volume":"8","author":"CM Bantle","year":"2020","unstructured":"Bantle CM, Hirst WD, Weihofen A, Shlevkov E (2020) Mitochondrial dysfunction in astrocytes: a role in Parkinson\u2019s disease? Front Cell Dev Biol 8:608026. https:\/\/doi.org\/10.3389\/fcell.2020.608026","journal-title":"Front Cell Dev Biol"},{"key":"1374_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0165-0270(88)90171-9","volume":"24","author":"JB Becker","year":"1988","unstructured":"Becker JB, Adams F, Robinson TE (1988) Intraventricular microdialysis: a new method for determining monoamine metabolite concentrations in the cerebrospinal fluid of freely moving rats. J Neurosci Methods 24:259\u2013269. https:\/\/doi.org\/10.1016\/0165-0270(88)90171-9","journal-title":"J Neurosci Methods"},{"key":"1374_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fnsys.2011.00092","volume":"5","author":"J Blesa","year":"2011","unstructured":"Blesa J, Juri C, Garcia-Cabezas MA, Adanez R, Sanchez-Gonzalez MA, Cavada C, Obeso JA (2011) Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion: a possible compensatory mechanism in Parkinson\u2019s disease. Front Syst Neurosci 5:92. https:\/\/doi.org\/10.3389\/fnsys.2011.00092","journal-title":"Front Syst Neurosci"},{"key":"1374_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"1374_CR7","doi-asserted-by":"publisher","DOI":"10.1523\/eneuro.0110-20.2020","author":"J Burtscher","year":"2020","unstructured":"Burtscher J, Copin J-C, Sandi C, Lashuel HA (2020) Pronounced \u03b1-synuclein pathology in a seeding-based mouse model is not sufficient to induce mitochondrial respiration deficits in the striatum and amygdala. eneuro ENEURO. https:\/\/doi.org\/10.1523\/eneuro.0110-20.2020","journal-title":"eneuro ENEURO"},{"key":"1374_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2020.101772","volume":"187","author":"PJ Carling","year":"2020","unstructured":"Carling PJ, Mortiboys H, Green C, Mihaylov S, Sandor C, Schwartzentruber A, Taylor R, Wei W, Hastings C, Wong S et al (2020) Deep phenotyping of peripheral tissue facilitates mechanistic disease stratification in sporadic Parkinson\u2019s disease. Prog Neurobiol 187:101772. https:\/\/doi.org\/10.1016\/j.pneurobio.2020.101772","journal-title":"Prog Neurobiol"},{"key":"1374_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.etp.2016.12.007","volume":"69","author":"CH Carriere","year":"2017","unstructured":"Carriere CH, Kang NH, Niles LP (2017) Bilateral upregulation of alpha-synuclein expression in the mouse substantia nigra by intracranial rotenone treatment. Exp Toxicol Pathol 69:109\u2013114. https:\/\/doi.org\/10.1016\/j.etp.2016.12.007","journal-title":"Exp Toxicol Pathol"},{"key":"1374_CR10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M et al (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet 364:1167\u20131169","journal-title":"Lancet"},{"key":"1374_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-016-1654-y","author":"M Chen","year":"2016","unstructured":"Chen M, Liu J, Lu Y, Duan C, Lu L, Gao G, Chan P, Yu S, Yang H (2016) Age-dependent alpha-synuclein accumulation is correlated with elevation of mitochondrial TRPC3 in the brains of monkeys and mice. J Neural Transm (Vienna). https:\/\/doi.org\/10.1007\/s00702-016-1654-y","journal-title":"J Neural Transm (Vienna)"},{"key":"1374_CR12","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.stemcr.2016.08.012","volume":"7","author":"SY Chung","year":"2016","unstructured":"Chung SY, Kishinevsky S, Mazzulli JR, Graziotto J, Mrejeru A, Mosharov EV, Puspita L, Valiulahi P, Sulzer D, Milner TA et al (2016) Parkin and PINK1 patient iPSC-derived midbrain dopamine neurons exhibit mitochondrial dysfunction and alpha-synuclein accumulation. Stem Cell Rep 7:664\u2013677. https:\/\/doi.org\/10.1016\/j.stemcr.2016.08.012","journal-title":"Stem Cell Rep"},{"key":"1374_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neuroscience.2020.04.032","volume":"437","author":"RB Creed","year":"2020","unstructured":"Creed RB, Goldberg MS (2020) Enhanced susceptibility of PINK1 knockout rats to alpha-synuclein fibrils. Neuroscience 437:64\u201375. https:\/\/doi.org\/10.1016\/j.neuroscience.2020.04.032","journal-title":"Neuroscience"},{"key":"1374_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neuroscience.2020.04.032","volume":"437","author":"RB Creed","year":"2020","unstructured":"Creed RB, Goldberg MS (2020) Enhanced susceptibility of PINK1 knockout rats to \u03b1-synuclein fibrils. Neuroscience 437:64\u201375. https:\/\/doi.org\/10.1016\/j.neuroscience.2020.04.032","journal-title":"Neuroscience"},{"key":"1374_CR15","doi-asserted-by":"publisher","first-page":"342r378","DOI":"10.1126\/scitranslmed.aaf3634","volume":"8","author":"R Di Maio","year":"2016","unstructured":"Di Maio R, Barrett PJ, Hoffman EK, Barrett CW, Zharikov A, Borah A, Hu X, McCoy J, Chu CT, Burton EA et al (2016) alpha-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease. Sci Transl Med 8:342r378. https:\/\/doi.org\/10.1126\/scitranslmed.aaf3634","journal-title":"Sci Transl Med"},{"key":"1374_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-018-1171-z","volume":"15","author":"MF Duffy","year":"2018","unstructured":"Duffy MF, Collier TJ, Patterson JR, Kemp CJ, Luk KC, Tansey MG, Paumier KL, Kanaan NM, Fischer DL, Polinski NK et al (2018) Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration. J Neuroinflammation 15:129. https:\/\/doi.org\/10.1186\/s12974-018-1171-z","journal-title":"J Neuroinflammation"},{"key":"1374_CR17","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1093\/brain\/awz065","volume":"142","author":"V Durante","year":"2019","unstructured":"Durante V, De Iure A, Loffredo V, Vaikath N, De Risi M, Paciotti S, Quiroga-Varela A, Chiasserini D, Mellone M, Mazzocchetti P et al (2019) Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration. Brain 142:1365\u20131385. https:\/\/doi.org\/10.1093\/brain\/awz065","journal-title":"Brain"},{"key":"1374_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00401-019-02105-w","volume":"139","author":"D Erskine","year":"2020","unstructured":"Erskine D, Reeve AK, Polvikoski T, Schaefer AM, Taylor RW, Lax NZ, El-Agnaf O, Attems J, Gorman GS, Turnbull DM et al (2020) Lewy body pathology is more prevalent in older individuals with mitochondrial disease than controls. Acta Neuropathol 139:219\u2013221. https:\/\/doi.org\/10.1007\/s00401-019-02105-w","journal-title":"Acta Neuropathol"},{"key":"1374_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.134899","volume":"725","author":"M Fayyad","year":"2020","unstructured":"Fayyad M, Majbour NK, Vaikath NN, Erskine D, El-Tarawneh H, Sudhakaran IP, Abdesselem H, El-Agnaf OMA (2020) Generation of monoclonal antibodies against phosphorylated alpha-Synuclein at serine 129: Research tools for synucleinopathies. Neurosci Lett 725:134899. https:\/\/doi.org\/10.1016\/j.neulet.2020.134899","journal-title":"Neurosci Lett"},{"key":"1374_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.nbd.2004.07.001","volume":"17","author":"PO Fernagut","year":"2004","unstructured":"Fernagut PO, Chesselet MF (2004) Alpha-synuclein and transgenic mouse models. Neurobiol Dis 17:123\u2013130","journal-title":"Neurobiol Dis"},{"key":"1374_CR21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-017-1794-7","volume":"135","author":"IH Fl\u00f8nes","year":"2018","unstructured":"Fl\u00f8nes IH, Fernandez-Vizarra E, Lykouri M, Brakedal B, Skeie GO, Miletic H, Lilleng PK, Alves G, Tysnes O-B, Haugarvoll K et al (2018) Neuronal complex I deficiency occurs throughout the Parkinson\u2019s disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage. Acta Neuropathol 135:409\u2013425. https:\/\/doi.org\/10.1007\/s00401-017-1794-7","journal-title":"Acta Neuropathol"},{"key":"1374_CR22","doi-asserted-by":"publisher","first-page":"10392","DOI":"10.1074\/jbc.RA119.007743","volume":"294","author":"JM Froula","year":"2019","unstructured":"Froula JM, Castellana-Cruz M, Anabtawi NM, Camino JD, Chen SW, Thrasher DR, Freire J, Yazdi AA, Fleming S, Dobson CM et al (2019) Defining alpha-synuclein species responsible for Parkinson\u2019s disease phenotypes in mice. J Biol Chem 294:10392\u201310406. https:\/\/doi.org\/10.1074\/jbc.RA119.007743","journal-title":"J Biol Chem"},{"key":"1374_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0537-x","author":"JM Froula","year":"2018","unstructured":"Froula JM, Henderson BW, Gonzalez JC, Vaden JH, McLean JW, Wu Y, Banumurthy G, Overstreet-Wadiche L, Herskowitz JH, Volpicelli-Daley LA (2018) \u03b1-Synuclein fibril-induced paradoxical structural and functional defects in hippocampal neurons. Acta Neuropathol Commun. https:\/\/doi.org\/10.1186\/s40478-018-0537-x","journal-title":"Acta Neuropathol Commun"},{"key":"1374_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160\u2013164","journal-title":"Nat Cell Biol"},{"key":"1374_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2091-2","author":"GK Ganjam","year":"2019","unstructured":"Ganjam GK, Bolte K, Matschke LA, Neitemeier S, Dolga AM, H\u00f6llerhage M, H\u00f6glinger GU, Adamczyk A, Decher N, Oertel WH et al (2019) Mitochondrial damage by \u03b1-synuclein causes cell death in human dopaminergic neurons. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-019-2091-2","journal-title":"Cell Death Dis"},{"key":"1374_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/glia.24149","author":"P Garcia","year":"2022","unstructured":"Garcia P, Jurgens-Wemheuer W, Uriarte Huarte O, Michelucci A, Masuch A, Brioschi S, Weihofen A, Koncina E, Coowar D, Heurtaux T et al (2022) Neurodegeneration and neuroinflammation are linked, but independent of alpha-synuclein inclusions, in a seeding\/spreading mouse model of Parkinson\u2019s disease. Glia. https:\/\/doi.org\/10.1002\/glia.24149","journal-title":"Glia"},{"key":"1374_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00089","author":"P Garcia-Esparcia","year":"2017","unstructured":"Garcia-Esparcia P, L\u00f3pez-Gonz\u00e1lez I, Grau-Rivera O, Garc\u00eda-Garrido MF, Konetti A, Llorens F, Zafar S, Carmona M, Del Rio JA, Zerr I et al (2017) Dementia with Lewy bodies: molecular pathology in the frontal cortex in typical and rapidly progressive forms. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2017.00089","journal-title":"Front Neurol"},{"key":"1374_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40478-017-0494-9","volume":"5","author":"AS Harms","year":"2017","unstructured":"Harms AS, Delic V, Thome AD, Bryant N, Liu Z, Chandra S, Jurkuvenaite A, West AB (2017) alpha-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration. Acta Neuropathol Commun 5:85. https:\/\/doi.org\/10.1186\/s40478-017-0494-9","journal-title":"Acta Neuropathol Commun"},{"key":"1374_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-00985-8","author":"C Hatton","year":"2020","unstructured":"Hatton C, Reeve A, Lax NZ, Blain A, Ng YS, El-Agnaf O, Attems J, Taylor J-P, Turnbull D, Erskine D (2020) Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies. Acta Neuropathol Commun. https:\/\/doi.org\/10.1186\/s40478-020-00985-8","journal-title":"Acta Neuropathol Commun"},{"key":"1374_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1756-6606-5-35","volume":"5","author":"Y Imaizumi","year":"2012","unstructured":"Imaizumi Y, Okada Y, Akamatsu W, Koike M, Kuzumaki N, Hayakawa H, Nihira T, Kobayashi T, Ohyama M, Sato S et al (2012) Mitochondrial dysfunction associated with increased oxidative stress and alpha-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue. Mol Brain 5:35. https:\/\/doi.org\/10.1186\/1756-6606-5-35","journal-title":"Mol Brain"},{"key":"1374_CR31","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1373\/clinchem.2006.078873","volume":"53","author":"AJ Janssen","year":"2007","unstructured":"Janssen AJ, Trijbels FJ, Sengers RC, Smeitink JA, Van Den Heuvel LP, Wintjes LT, Stoltenborg-Hogenkamp BJ, Rodenburg RJ (2007) Spectrophotometric assay for complex I of the respiratory Chain in tissue samples and cultured fibroblasts. Clin Chem 53:729\u2013734. https:\/\/doi.org\/10.1373\/clinchem.2006.078873","journal-title":"Clin Chem"},{"key":"1374_CR32","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrn.2017.75","volume":"18","author":"JB Koprich","year":"2017","unstructured":"Koprich JB, Kalia LV, Brotchie JM (2017) Animal models of alpha-synucleinopathy for Parkinson disease drug development. Nat Rev Neurosci 18:515\u2013529. https:\/\/doi.org\/10.1038\/nrn.2017.75","journal-title":"Nat Rev Neurosci"},{"key":"1374_CR33","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.3233\/jpd-179006","volume":"7","author":"JW Langston","year":"2017","unstructured":"Langston JW (2017) The MPTP story. J Parkinsons Dis 7:S11\u2013S19. https:\/\/doi.org\/10.3233\/jpd-179006","journal-title":"J Parkinsons Dis"},{"key":"1374_CR34","doi-asserted-by":"publisher","first-page":"10510","DOI":"10.1523\/jneurosci.1659-16.2016","volume":"36","author":"MH Ludtmann","year":"2016","unstructured":"Ludtmann MH, Angelova PR, Ninkina NN, Gandhi S, Buchman VL, Abramov AY (2016) Monomeric alpha-synuclein exerts a physiological role on brain ATP synthase. J Neurosci 36:10510\u201310521. https:\/\/doi.org\/10.1523\/jneurosci.1659-16.2016","journal-title":"J Neurosci"},{"key":"1374_CR35","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V, Carroll J, Zhang B, O\u2019Brien P, Trojanowski JQ, Lee VM (2012) Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338:949\u2013953. https:\/\/doi.org\/10.1126\/science.1227157","journal-title":"Science"},{"key":"1374_CR36","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk KC, Song C, O\u2019Brien P, Stieber A, Branch JR, Brunden KR, Trojanowski JQ, Lee VM (2009) Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci U S A 106:20051\u201320056. https:\/\/doi.org\/10.1073\/pnas.0908005106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1374_CR37","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1073\/pnas.1913904117","volume":"117","author":"A-L Mahul-Mellier","year":"2020","unstructured":"Mahul-Mellier A-L, Burtscher J, Maharjan N, Weerens L, Croisier M, Kuttler F, Leleu M, Knott GW, Lashuel HA (2020) The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration. Proc Natl Acad Sci 117:4971\u20134982. https:\/\/doi.org\/10.1073\/pnas.1913904117","journal-title":"Proc Natl Acad Sci"},{"key":"1374_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","volume":"46","author":"AB Malpartida","year":"2021","unstructured":"Malpartida AB, Williamson M, Narendra DP, Wade-Martins R, Ryan BJ (2021) Mitochondrial dysfunction and mitophagy in Parkinson\u2019s disease: from mechanism to therapy. Trends Biochem Sci 46:329\u2013343. https:\/\/doi.org\/10.1016\/j.tibs.2020.11.007","journal-title":"Trends Biochem Sci"},{"key":"1374_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13024-016-0113-4","volume":"11","author":"DM Mason","year":"2016","unstructured":"Mason DM, Nouraei N, Pant DB, Miner KM, Hutchison DF, Luk KC, Stolz JF, Leak RK (2016) Transmission of alpha-synucleinopathy from olfactory structures deep into the temporal lobe. Mol Neurodegener 11:49. https:\/\/doi.org\/10.1186\/s13024-016-0113-4","journal-title":"Mol Neurodegener"},{"key":"1374_CR40","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awt037","volume":"136","author":"M Masuda-Suzukake","year":"2013","unstructured":"Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H, Mann DMA, Hasegawa M (2013) Prion-like spreading of pathological \u03b1-synuclein in brain. Brain 136:1128\u20131138. https:\/\/doi.org\/10.1093\/brain\/awt037","journal-title":"Brain"},{"key":"1374_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-019-0730-6","author":"G Monzio Compagnoni","year":"2019","unstructured":"Monzio Compagnoni G, Di Fonzo A (2019) Understanding the pathogenesis of multiple system atrophy: state of the art and future perspectives. Acta Neuropathol Commun. https:\/\/doi.org\/10.1186\/s40478-019-0730-6","journal-title":"Acta Neuropathol Commun"},{"key":"1374_CR42","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1016\/j.bbadis.2018.09.018","volume":"1864","author":"G Monzio Compagnoni","year":"2018","unstructured":"Monzio Compagnoni G, Kleiner G, Bordoni A, Fortunato F, Ronchi D, Salani S, Guida M, Corti C, Pichler I, Bergamini C et al (2018) Mitochondrial dysfunction in fibroblasts of Multiple System Atrophy. Biochimica et Biophys Acta (BBA) Mol Basis of Disease 1864:3588\u20133597. https:\/\/doi.org\/10.1016\/j.bbadis.2018.09.018","journal-title":"Biochimica et Biophys Acta (BBA) Mol Basis of Disease"},{"key":"1374_CR43","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.neurobiolaging.2013.03.016","volume":"34","author":"SK Muller","year":"2013","unstructured":"Muller SK, Bender A, Laub C, Hogen T, Schlaudraff F, Liss B, Klopstock T, Elstner M (2013) Lewy body pathology is associated with mitochondrial DNA damage in Parkinson\u2019s disease. Neurobiol Aging 34:2231\u20132233. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.03.016","journal-title":"Neurobiol Aging"},{"key":"1374_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0587-0","author":"A Okuzumi","year":"2018","unstructured":"Okuzumi A, Kurosawa M, Hatano T, Takanashi M, Nojiri S, Fukuhara T, Yamanaka T, Miyazaki H, Yoshinaga S, Furukawa Y et al (2018) Rapid dissemination of alpha-synuclein seeds through neural circuits in an in-vivo prion-like seeding experiment. Acta Neuropathol Commun. https:\/\/doi.org\/10.1186\/s40478-018-0587-0","journal-title":"Acta Neuropathol Commun"},{"key":"1374_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104525","volume":"130","author":"JR Patterson","year":"2019","unstructured":"Patterson JR, Duffy MF, Kemp CJ, Howe JW, Collier TJ, Stoll AC, Miller KM, Patel P, Levine N, Moore DJ et al (2019) Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal alpha-synuclein preformed fibrils. Neurobiol Dis 130:104525. https:\/\/doi.org\/10.1016\/j.nbd.2019.104525","journal-title":"Neurobiol Dis"},{"key":"1374_CR46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.nbd.2015.06.003","volume":"82","author":"KL Paumier","year":"2015","unstructured":"Paumier KL, Luk KC, Manfredsson FP, Kanaan NM, Lipton JW, Collier TJ, Steece-Collier K, Kemp CJ, Celano S, Schulz E et al (2015) Intrastriatal injection of pre-formed mouse alpha-synuclein fibrils into rats triggers alpha-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiol Dis 82:185\u2013199. https:\/\/doi.org\/10.1016\/j.nbd.2015.06.003","journal-title":"Neurobiol Dis"},{"key":"1374_CR47","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W Peelaerts","year":"2015","unstructured":"Peelaerts W, Bousset L, Van der Perren A, Moskalyuk A, Pulizzi R, Giugliano M, Van den Haute C, Melki R, Baekelandt V (2015) alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522:340\u2013344. https:\/\/doi.org\/10.1038\/nature14547","journal-title":"Nature"},{"key":"1374_CR48","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047","journal-title":"Science"},{"key":"1374_CR49","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/archneurol.2011.2675","volume":"69","author":"AK Reeve","year":"2012","unstructured":"Reeve AK (2012) Relationship between mitochondria and \u03b1-synuclein. Arch Neurol 69:385. https:\/\/doi.org\/10.1001\/archneurol.2011.2675","journal-title":"Arch Neurol"},{"key":"1374_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0006-8993(88)91560-0","volume":"450","author":"TE Robinson","year":"1988","unstructured":"Robinson TE, Whishaw IQ (1988) Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res 450:209\u2013224. https:\/\/doi.org\/10.1016\/0006-8993(88)91560-0","journal-title":"Brain Res"},{"key":"1374_CR51","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/cne.1098","volume":"432","author":"A Roedter","year":"2001","unstructured":"Roedter A, Winkler C, Samii M, Walter GF, Brandis A, Nikkhah G (2001) Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways. J Comp Neurol 432:217\u2013229. https:\/\/doi.org\/10.1002\/cne.1098","journal-title":"J Comp Neurol"},{"key":"1374_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2021.102355","volume":"95","author":"WM Rosencrans","year":"2021","unstructured":"Rosencrans WM, Aguilella VM, Rostovtseva TK, Bezrukov SM (2021) \u03b1-Synuclein emerges as a potent regulator of VDAC-facilitated calcium transport. Cell Calcium 95:102355. https:\/\/doi.org\/10.1016\/j.ceca.2021.102355","journal-title":"Cell Calcium"},{"key":"1374_CR53","doi-asserted-by":"publisher","first-page":"12368","DOI":"10.1523\/jneurosci.2102-14.2014","volume":"34","author":"AN Sacino","year":"2014","unstructured":"Sacino AN, Brooks M, McKinney AB, Thomas MA, Shaw G, Golde TE, Giasson BI (2014) Brain injection of -Synuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker. J Neurosci 34:12368\u201312378. https:\/\/doi.org\/10.1523\/jneurosci.2102-14.2014","journal-title":"J Neurosci"},{"key":"1374_CR54","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1042\/bj1140597","volume":"114","author":"D Shepherd","year":"1969","unstructured":"Shepherd D, Garland PB (1969) The kinetic properties of citrate synthase from rat liver mitochondria. Biochem J 114:597\u2013610. https:\/\/doi.org\/10.1042\/bj1140597","journal-title":"Biochem J"},{"key":"1374_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-017-0413-0","author":"A Shimozawa","year":"2017","unstructured":"Shimozawa A, Ono M, Takahara D, Tarutani A, Imura S, Masuda-Suzukake M, Higuchi M, Yanai K, Hisanaga S-I, Hasegawa M (2017) Propagation of pathological \u03b1-synuclein in marmoset brain. Acta Neuropathol Commun. https:\/\/doi.org\/10.1186\/s40478-017-0413-0","journal-title":"Acta Neuropathol Commun"},{"key":"1374_CR56","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R et al (2003) alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science 302:841","journal-title":"Science"},{"key":"1374_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2017.06.052","volume":"710","author":"EF Smith","year":"2019","unstructured":"Smith EF, Shaw PJ, De Vos KJ (2019) The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett 710:132933. https:\/\/doi.org\/10.1016\/j.neulet.2017.06.052","journal-title":"Neurosci Lett"},{"key":"1374_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0182-z","author":"ZA Sorrentino","year":"2017","unstructured":"Sorrentino ZA, Brooks MMT, Hudson V, Rutherford NJ, Golde TE, Giasson BI, Chakrabarty P (2017) Intrastriatal injection of \u03b1-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-017-0182-z","journal-title":"Mol Neurodegener"},{"key":"1374_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104708","volume":"134","author":"LE Stoyka","year":"2020","unstructured":"Stoyka LE, Arrant AE, Thrasher DR, Russell DL, Freire J, Mahoney CL, Narayanan A, Dib AG, Standaert DG, Volpicelli-Daley LA (2020) Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded \u03b1-synuclein inclusions. Neurobiol Dis 134:104708. https:\/\/doi.org\/10.1016\/j.nbd.2019.104708","journal-title":"Neurobiol Dis"},{"key":"1374_CR60","doi-asserted-by":"publisher","DOI":"10.1523\/eneuro.0458-20.2021","author":"LE Stoyka","year":"2021","unstructured":"Stoyka LE, Mahoney CL, Thrasher DR, Russell DL, Cook AK, Harris AT, Narayanan A, Janado TP, Standaert DG, Roberson ED et al (2021) Templated \u03b1-synuclein inclusion formation is independent of endogenous tau. eneuro ENEURO. https:\/\/doi.org\/10.1523\/eneuro.0458-20.2021","journal-title":"eneuro ENEURO"},{"key":"1374_CR61","doi-asserted-by":"publisher","first-page":"18675","DOI":"10.1074\/jbc.m116.734707","volume":"291","author":"A Tarutani","year":"2016","unstructured":"Tarutani A, Suzuki G, Shimozawa A, Nonaka T, Akiyama H, Hisanaga S-I, Hasegawa M (2016) The effect of fragmented pathogenic \u03b1-synuclein seeds on prion-like propagation. J Biol Chem 291:18675\u201318688. https:\/\/doi.org\/10.1074\/jbc.m116.734707","journal-title":"J Biol Chem"},{"key":"1374_CR62","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/1098-1063(2000)10:4<411::AID-HIPO7>3.0.CO;2-A","volume":"10","author":"AM Thierry","year":"2000","unstructured":"Thierry AM, Gioanni Y, Degenetais E, Glowinski J (2000) Hippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics. Hippocampus 10:411\u2013419. https:\/\/doi.org\/10.1002\/1098-1063(2000)10:4%3c411::AID-HIPO7%3e3.0.CO;2-A","journal-title":"Hippocampus"},{"key":"1374_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22108-0","author":"VA Trinkaus","year":"2021","unstructured":"Trinkaus VA, Riera-Tur I, Mart\u00ednez-S\u00e1nchez A, B\u00e4uerlein FJB, Guo Q, Arzberger T, Baumeister W, Dudanova I, Hipp MS, Hartl FU et al (2021) In situ architecture of neuronal \u03b1-Synuclein inclusions. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-021-22108-0","journal-title":"Nat Commun"},{"key":"1374_CR64","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.celrep.2015.01.060","volume":"10","author":"K Valerie","year":"2015","unstructured":"Valerie K, Leah K, Randall V (2015) Progressive aggregation of alpha-synuclein and selective degeneration of lewy inclusion-bearing neurons in a mouse model of parkinsonism. Cell Rep 10:1252\u20131260. https:\/\/doi.org\/10.1016\/j.celrep.2015.01.060","journal-title":"Cell Rep"},{"key":"1374_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2016.09.003","author":"NP Visanji","year":"2016","unstructured":"Visanji NP, Brotchie JM, Kalia LV, Koprich JB, Tandon A, Watts JC, Lang AE (2016) alpha-Synuclein-based animal models of Parkinson\u2019s disease challenges and opportunities in a New Era. Trends Neurosci. https:\/\/doi.org\/10.1016\/j.tins.2016.09.003","journal-title":"Trends Neurosci"},{"issue":"Suppl 1","key":"1374_CR66","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/jnc.13627","volume":"139","author":"LA Volpicelli-Daley","year":"2016","unstructured":"Volpicelli-Daley LA, Kirik D, Stoyka LE, Standaert DG, Harms AS (2016) How can rAAV-alpha-synuclein and the fibril alpha-synuclein models advance our understanding of Parkinson\u2019s disease? J Neurochem 139(Suppl 1):131\u2013155. https:\/\/doi.org\/10.1111\/jnc.13627","journal-title":"J Neurochem"},{"key":"1374_CR67","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/nprot.2014.143","volume":"9","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley LA, Luk KC, Lee VM (2014) Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to Lewy body and Lewy neurite-like aggregates. Nat Protoc 9:2135\u20132146. https:\/\/doi.org\/10.1038\/nprot.2014.143","journal-title":"Nat Protoc"},{"key":"1374_CR68","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, Meaney DF, Trojanowski JQ, Lee VM (2011) Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72:57\u201371. https:\/\/doi.org\/10.1016\/j.neuron.2011.08.033","journal-title":"Neuron"},{"key":"1374_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00376-6","author":"W Wang","year":"2020","unstructured":"Wang W, Zhao F, Ma X, Perry G, Zhu X (2020) Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-020-00376-6","journal-title":"Mol Neurodegener"},{"key":"1374_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-019-0696-4","author":"X Wang","year":"2019","unstructured":"Wang X, Becker K, Levine N, Zhang M, Lieberman AP, Moore DJ, Ma J (2019) Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration. Acta Neuropathol Commun. https:\/\/doi.org\/10.1186\/s40478-019-0696-4","journal-title":"Acta Neuropathol Commun"},{"key":"1374_CR71","doi-asserted-by":"publisher","first-page":"5080","DOI":"10.1523\/jneurosci.0060-19.2019","volume":"39","author":"Q Wu","year":"2019","unstructured":"Wu Q, Takano H, Riddle DM, Trojanowski JQ, Coulter DA, Lee VMY (2019) \u03b1-Synuclein (\u03b1Syn) preformed fibrils induce endogenous \u03b1Syn aggregation, compromise synaptic activity and enhance synapse loss in cultured excitatory hippocampal neurons. J Neurosci 39:5080\u20135094. https:\/\/doi.org\/10.1523\/jneurosci.0060-19.2019","journal-title":"J Neurosci"},{"key":"1374_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(86)90893-0","volume":"376","author":"T Zetterstrom","year":"1986","unstructured":"Zetterstrom T, Herrera-Marschitz M, Ungerstedt U (1986) Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis. Brain Res 376:1\u20137. https:\/\/doi.org\/10.1016\/0006-8993(86)90893-0","journal-title":"Brain Res"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01374-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-022-01374-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01374-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T10:04:24Z","timestamp":1653300264000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-022-01374-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1374"],"URL":"https:\/\/doi.org\/10.1186\/s40478-022-01374-z","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,23]]},"assertion":[{"value":"8 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All use of animals was reviewed and approved by the UAB Institutional Animal Care and Use Committee prior to initiation of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial or non-financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}